HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
190822.0,241826,2180-06-16 07:29:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 FEVER - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
         [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and fever.
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with fever,
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue for poss [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - consider EEG
   .
   # RLL infiltrate: Pt with MS changes, witnessed emesis and likely
   aspiration event.  Currently tachypneic and febrile though oxygenating
   well, CXR concerning for RLL infiltrate awaiting final read. Pt just
   completed a course of chemo and WBC trending down.  Pt is now hosp day
   3 and will need to cover hosp acq organisms.  Lactate normal on initial
   gas
   - start empiric Vanc/Zosyn
   - strict aspiration precautions
   - monitor resp status serially
   - serial ABGs/lactates
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with NS IVF at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 FEVER - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
         [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and fever.
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with fever,
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue for poss [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - consider EEG
   .
   # RLL infiltrate: Pt with MS changes, witnessed emesis and likely
   aspiration event.  Currently tachypneic and febrile though oxygenating
   well, CXR concerning for RLL infiltrate awaiting final read. Pt just
   completed a course of chemo and WBC trending down.  Pt is now hosp day
   3 and will need to cover hosp acq organisms.  Lactate normal on initial
   gas
   - start empiric Vanc/Zosyn
   - strict aspiration precautions
   - monitor resp status serially
   - serial ABGs/lactates
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with NS IVF at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health progress in the ICU as follows:

The patient is a 74-year-old woman with recurrent follicular cell lymphoma who was admitted to the ICU for acute mental status changes and fever. She was transferred to the ICU after completing a chemotherapy regimen with known neurotoxicity. The patient's mental status changes are attributed to unclear etiology, but concern for [**Name (NI) 8017**] toxicity is high given recent chemotherapy. Infection is also a likely contributor, with fever, tachycardia, and tachypnea. A CXR shows a possible RLL infiltrate.

The patient's vital signs are:

* Temperature: 101.8°F (38.8°C)
* Heart rate: 105 bpm
* Blood pressure: 152/77 mmHg
* Respiratory rate: 19 breaths per minute
* Oxygen saturation: 97%
* White blood cell count: 6.2 K/uL
* Hematocrit: 24.5%
* Platelet count: 147 K/uL
* Creatinine: 0.9 mg/dL
* Total CO2: 19 mmHg
* Glucose: 106 mg/dL

The patient's physical examination reveals:

* Altered mental status
* Nausea and vomiting
* Mildly tachycardic
* Normal S1 and S2 heart sounds
* No murmurs, rubs, or gallops
* Soft, non-tender abdomen with no palpable masses
* Cool, 2+ radial and DP pulses
* No edema

The patient's laboratory results show:

* Mild transaminitis and elevated LDH
* Normal ammonia level
* Normal lactate level
* Normal calcium and magnesium levels
* Elevated potassium level

The patient is currently receiving:

* Methylene blue for possible [**Name (NI) 8017**] toxicity
* Zofran and compazine for nausea and vomiting
* Empiric Vanc/Zosyn for suspected infection
* Famotidine for stress ulcer prophylaxis
* IV fluids at 100cc/hr with electrolyte repletion as needed

Potential medical complications that can arise from this patient's condition include:

* [**Name (NI) 8017**] neurotoxicity
* Infection, particularly pneumonia or urinary tract infection
* Aspiration pneumonitis
* Hepatic encephalopathy
* Electrolyte imbalances
* Renal failure
* Sepsis

The patient's code status is full code, and her disposition is pending."
190822.0,241826,2180-06-16 07:29:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 [**Year (4 digits) **] - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula, 2L
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
        [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and [**Year (4 digits) **].
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with [**Name (NI) **],
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue and thiamine for [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - f/u EEG
   .
   # ID: Pt with MS changes, witnessed emesis and likely aspiration
   event.  Currently tachypneic and febrile though oxygenating well, CXR
   concerning for RLL infiltrate although on f/u CXR today appears to be
   resolved. Pt just completed a course of chemo and WBC trending down.
   Pt is now hosp day 3 and will need to cover hosp acq organisms.
   Lactate normal on initial gas. Arrived in [**Hospital Unit Name 4**] yesterday with T 101.8,
   since then has been afebrile.
   - cont empiric Vanc/Zosyn for 48 hrs if neg cultures/afebrile
   - strict aspiration precautions
   - monitor resp status serially
   - ABGs/lactates prn
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   - if worsens will place NGT
   .
   # Non gap acidosis: likely secondary to NS fluid resuscitation
   - will continue to trend on AM lytes
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with LR at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM x2
   Prophylaxis:
   DVT:
   Stress ulcer: famotidine
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for methylene blue treatment
   ------ Protected Section ------
   MICU ATTENDING PROGRESS NOTE
   I saw and examined the patient and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   resident note, including the assessment and plan. I would emphasize and
   add the following points: 74 yo F h/o recurrent follicular cell
   lymphoma admitted 3 days ago for induction chemotherapy
   (Ofatumumab/ICE, per phase II study).   Transferred to [**Hospital Unit Name 4**] for further
   management of acutely altered MS [**First Name (Titles) **] [**Last Name (Titles) **] concerning for infection
   (asp pna), drug reaction, or possible CSF event.
   Exam notable for Tm 101.8-->98  HR 105  BP 150/70  20's  97% 2L NC
   Somnolent but more arousable this morning, intermittenly follows
   commands, answers questions, PERRLA, CTA X d b/b BS, tachy rr s1s2,
   soft +BS, moves all 4, no obvious focal deficit w/ limited cooperation
   with exam
   Labs reviewed:    wbc 6.2, plt 147, hct 24.5, cr 0.9, ag 10, inr 1.0,
   lfts stable
   Bl/urine cx's pending w/ ngtd
   CXR RML infiltrate appears much less pronounced
   Acute MS change is very concerning for [**Last Name (Titles) 8017**] toxicity vs acute CNS
   process or sz.  Her recent [**Last Name (Titles) **] is concerning for infection and given
   her CXR findings and history of emesis, we are treating for
   HAP/aspiration pna.  Agree with plan to continue broad antibx for
   hospital acquired infection and aspiration pna (zosyn, vanco), tapering
   pending cx results. She is getting methylene blue for ? [**Last Name (Titles) 8017**] toxicity.
   Will F/u eeg and MRI results, and additional neurology recs.  She
   remains NPO with aspiration precautions, monitoring for signs of
   hypoventilation or inability to protect airway/secretions. We continue
   maintenance fluids while NPO, using LR given her NAGMA which is most
   likely [**12-20**] fluids given with her chemo. Continue compazine for
   nausea--and consider NGT placement if emesis recurs. Follow cbc as
   counts will likely nadir in the next few days post chemo. ICU: Boots,
   H2B, port, 2PIVs.  Remainder of plan as outlined in resident note.
   Patient is critically ill
   Total time: 50 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 143**] [**Last Name (NamePattern1) 144**], MD
   on:[**2180-6-16**] 04:08 PM ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 [**Year (4 digits) **] - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula, 2L
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
        [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and [**Year (4 digits) **].
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with [**Name (NI) **],
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue and thiamine for [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - f/u EEG
   .
   # ID: Pt with MS changes, witnessed emesis and likely aspiration
   event.  Currently tachypneic and febrile though oxygenating well, CXR
   concerning for RLL infiltrate although on f/u CXR today appears to be
   resolved. Pt just completed a course of chemo and WBC trending down.
   Pt is now hosp day 3 and will need to cover hosp acq organisms.
   Lactate normal on initial gas. Arrived in [**Hospital Unit Name 4**] yesterday with T 101.8,
   since then has been afebrile.
   - cont empiric Vanc/Zosyn for 48 hrs if neg cultures/afebrile
   - strict aspiration precautions
   - monitor resp status serially
   - ABGs/lactates prn
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   - if worsens will place NGT
   .
   # Non gap acidosis: likely secondary to NS fluid resuscitation
   - will continue to trend on AM lytes
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with LR at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM x2
   Prophylaxis:
   DVT:
   Stress ulcer: famotidine
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for methylene blue treatment
   ------ Protected Section ------
   MICU ATTENDING PROGRESS NOTE
   I saw and examined the patient and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   resident note, including the assessment and plan. I would emphasize and
   add the following points: 74 yo F h/o recurrent follicular cell
   lymphoma admitted 3 days ago for induction chemotherapy
   (Ofatumumab/ICE, per phase II study).   Transferred to [**Hospital Unit Name 4**] for further
   management of acutely altered MS [**First Name (Titles) **] [**Last Name (Titles) **] concerning for infection
   (asp pna), drug reaction, or possible CSF event.
   Exam notable for Tm 101.8-->98  HR 105  BP 150/70  20's  97% 2L NC
   Somnolent but more arousable this morning, intermittenly follows
   commands, answers questions, PERRLA, CTA X d b/b BS, tachy rr s1s2,
   soft +BS, moves all 4, no obvious focal deficit w/ limited cooperation
   with exam
   Labs reviewed:    wbc 6.2, plt 147, hct 24.5, cr 0.9, ag 10, inr 1.0,
   lfts stable
   Bl/urine cx's pending w/ ngtd
   CXR RML infiltrate appears much less pronounced
   Acute MS change is very concerning for [**Last Name (Titles) 8017**] toxicity vs acute CNS
   process or sz.  Her recent [**Last Name (Titles) **] is concerning for infection and given
   her CXR findings and history of emesis, we are treating for
   HAP/aspiration pna.  Agree with plan to continue broad antibx for
   hospital acquired infection and aspiration pna (zosyn, vanco), tapering
   pending cx results. She is getting methylene blue for ? [**Last Name (Titles) 8017**] toxicity.
   Will F/u eeg and MRI results, and additional neurology recs.  She
   remains NPO with aspiration precautions, monitoring for signs of
   hypoventilation or inability to protect airway/secretions. We continue
   maintenance fluids while NPO, using LR given her NAGMA which is most
   likely [**12-20**] fluids given with her chemo. Continue compazine for
   nausea--and consider NGT placement if emesis recurs. Follow cbc as
   counts will likely nadir in the next few days post chemo. ICU: Boots,
   H2B, port, 2PIVs.  Remainder of plan as outlined in resident note.
   Patient is critically ill
   Total time: 50 min
   ------ Protected Section Addendum Entered By:[**Name (NI) 143**] [**Last Name (NamePattern1) 144**], MD
   on:[**2180-6-16**] 04:08 PM ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health progress in the ICU as follows:

The patient, a 74-year-old woman with recurrent follicular cell lymphoma, was admitted to the ICU for acute mental status changes and [**Year (4 digits) **] toxicity. She had undergone induction chemotherapy with Ofatumumab/ICE and was tolerating the regimen well until the development of acute mental status changes. The patient's current condition is characterized by:

* Altered mental status, not delirium
* Nausea and vomiting
* Tachypnea and tachycardia
* Fever
* Possible respiratory infection or aspiration pneumonia
* Abnormal laboratory results, including elevated white blood cell count, platelet count, and lactate dehydrogenase (LDH)

The patient's treatment plan includes:

* Continuation of methylene blue for [**Year (4 digits) **] toxicity
* Strict aspiration precautions
* Monitoring of respiratory status and serial ABGs
* Antibiotic coverage for hospital-acquired infection and aspiration pneumonia
* Follow-up with neurology recommendations
* Continuation of compazine for nausea
* Monitoring of electrolyte levels and hydration status

Potential medical complications that can arise from the patient's condition include:

* Respiratory failure due to aspiration pneumonia or respiratory infection
* Cardiac arrhythmias or cardiac arrest due to electrolyte imbalance or [**Year (4 digits) **] toxicity
* Neurological deterioration due to [**Year (4 digits) **] toxicity or other causes
* Infection or sepsis due to hospital-acquired organisms
* Gastrointestinal bleeding or perforation due to chemotherapy or [**Year (4 digits) **] toxicity

It is essential to closely monitor the patient's condition and adjust the treatment plan as necessary to prevent or manage these potential complications."
190822.0,241826,2180-06-16 07:29:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 FEVER - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula, 2L
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
        [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and fever.
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with fever,
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue and thiamine for [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - f/u EEG
   .
   # ID: Pt with MS changes, witnessed emesis and likely aspiration
   event.  Currently tachypneic and febrile though oxygenating well, CXR
   concerning for RLL infiltrate although on f/u CXR today appears to be
   resolved. Pt just completed a course of chemo and WBC trending down.
   Pt is now hosp day 3 and will need to cover hosp acq organisms.
   Lactate normal on initial gas. Arrived in [**Hospital Unit Name 4**] yesterday with T 101.8,
   since then has been afebrile.
   - cont empiric Vanc/Zosyn for 48 hrs if neg cultures/afebrile
   - strict aspiration precautions
   - monitor resp status serially
   - ABGs/lactates prn
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   - if worsens will place NGT
   .
   # Non gap acidosis: likely secondary to NS fluid resuscitation
   - will continue to trend on AM lytes
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with LR at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM x2
   Prophylaxis:
   DVT:
   Stress ulcer: famotidine
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for methylene blue treatment
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2180-6-15**] 11:15 AM
 URINE CULTURE - At [**2180-6-15**] 11:53 AM
 URINE CULTURE - At [**2180-6-15**] 02:00 PM
 NASAL SWAB - At [**2180-6-15**] 02:00 PM
 BLOOD CULTURED - At [**2180-6-15**] 02:10 PM
 EEG - At [**2180-6-15**] 05:50 PM
 INDWELLING PORT (PORTACATH) - START [**2180-6-15**] 06:16 PM
 MAGNETIC RESONANCE IMAGING - At [**2180-6-15**] 10:30 PM
 FEVER - 101.8
F - [**2180-6-15**] 12:00 PM
   ..
   -MRI: pending read
   -had n/v during MRI, ?aspiration, CXR: improved from AM
   -worsening nausea, KUB: nl, treated with zofran/compazine prn with
   effect
   -ABG all normal values
   -started methylene blue for [**Year (4 digits) **] toxicity
   -repleted K in AM
   Allergies:
   Demerol (Oral) (Meperidine Hcl)
   Nausea/Vomiting
   Last dose of Antibiotics:
   Vancomycin - [**2180-6-15**] 08:18 PM
   Piperacillin - [**2180-6-15**] 11:53 PM
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2180-6-15**] 07:41 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2180-6-16**] 07:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.8
C (101.8
   Tcurrent: 36.7
C (98
   HR: 105 (82 - 125) bpm
   BP: 152/77(97) {105/56(71) - 169/88(165)} mmHg
   RR: 19 (8 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 73.6 kg (admission): 72.8 kg
             Total In:
                                                                  1,841 mL
                                                                    303 mL
   PO:
             TF:
   IVF:
                                                                  1,841 mL
                                                                    303 mL
   Blood products:
   Total out:
                                                                  2,480 mL
                                                                    910 mL
   Urine:
                                                                  2,180 mL
                                                                    860 mL
   NG:
                                                                    300 mL
                                                                     50 mL
   Stool:
   Drains:
   Balance:
                                                                   -639 mL
                                                                   -607 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula, 2L
   SpO2: 97%
   ABG: 7.38/35/91.[**Numeric Identifier 253**]/18/-3
   Physical Examination
   HEENT: PERRL, sclera anicteric, dry MM, oropharynx clear,
   CV: mildly tachy, normal S1 and S2, no m/r/g
   PULM: CTAB, no w/r appreciated
   ABD: +BS, soft, non-tender, non-distended with no palpable masses.
   LIMBS: cool, 2+ radial and DP pulses, no edema.
   SKIN: Dry skin on legs, no rashes.
   NEURO: oriented to person only, pupils reactive, moving all extremities
   and intermittently follows commands
   Labs / Radiology
   147 K/uL
   8.1 g/dL
   106 mg/dL
   0.9 mg/dL
   18 mEq/L
   3.1 mEq/L
   24 mg/dL
   114 mEq/L
   142 mEq/L
   24.5 %
   6.2 K/uL
        [image002.jpg]
                             [**2180-6-15**]  11:41 AM
                             [**2180-6-15**]  07:47 PM
                             [**2180-6-16**]  03:56 AM
   WBC
   6.2
   Hct
   24.5
   Plt
   147
   Cr
   0.9
   TCO2
   19
   22
   Glucose
   106
   Other labs: PT / PTT / INR:12.3/24.2/1.0, ALT / AST:46/38, Alk Phos / T
   Bili:72/0.5, Lactic Acid:1.1 mmol/L, Ca++:7.5 mg/dL, Mg++:2.1 mg/dL,
   PO4:2.8 mg/dL
   .
   .
   BCx/Ucx pending
   .
   CXR: yesterday
   .
   MRI - pend
   Assessment and Plan
 ALTERED MENTAL STATUS (NOT DELIRIUM)
 NAUSEA / VOMITING
   .
   Assessment and Plan
   74-year-old woman with recurrent follicular cell lymphoma who presented
   for induction with protocol Ofatumumab/ICE and was transferred to the
   ICU for acute mental status changes and fever.
   .
   # Acute MS changes: Etiology unclear, though concerning for [**Name (NI) 8017**]
   toxicity given recent completion of chemo regimen with known
   neurotoxicity. Infection also likely contributing with fever,
   tachycardia and tachypnea.  CXR with possible RLL infiltrate.  Hepatic
   encephalopathy unlikely given only mild elevation to LFTs. This is very
   unlikely to be meningitis acquired since admission to hospital, will
   hold off on LP for now and d/w neuro.
   - cont methylene blue and thiamine for [**Name (NI) 8017**] toxicity.
   - strict aspiration precautions
   - f/u neuro recs
   - cont empiric Vanc/Zosyn
   - f/u MRI
   - f/u blood & urine cx
   - f/u EEG
   .
   # ID: Pt with MS changes, witnessed emesis and likely aspiration
   event.  Currently tachypneic and febrile though oxygenating well, CXR
   concerning for RLL infiltrate although on f/u CXR today appears to be
   resolved. Pt just completed a course of chemo and WBC trending down.
   Pt is now hosp day 3 and will need to cover hosp acq organisms.
   Lactate normal on initial gas. Arrived in [**Hospital Unit Name 4**] yesterday with T 101.8,
   since then has been afebrile.
   - cont empiric Vanc/Zosyn for 48 hrs if neg cultures/afebrile
   - strict aspiration precautions
   - monitor resp status serially
   - ABGs/lactates prn
   .
   # Nausea: KUB nl, likely [**12-20**] to [**Month/Day (2) **] toxicity
   - zofran prn / compazine prn
   - if worsens will place NGT
   .
   # Non gap acidosis: likely secondary to NS fluid resuscitation
   - will continue to trend on AM lytes
   .
   # Follicular Cell Lymphoma: Pt with recurrent disease after initial
   treatment with RCHOP, she was admitted for induction with ICE+study
   [**Doctor Last Name **] in protocol regimen.  Pt was tolerating regimen well until today
   when she developped acute MS changes.  Now concern for [**Doctor Last Name 8017**]
   neurotoxicity, methylene blue indicated and safe at 6GPD levels NL.
   - chemo regimen complete, continue aggressive hydration
   - start methylene blue 50mg q6hr for [**Doctor Last Name 8017**] neurotoxicity
   - f/u BMT recs
   .
   # Transaminitis: Patient has a mild transaminitis and elevated LDH
   likely due to chemo regimen and lysis of lymphoma cells.  MS changes
   unlikely due to hepatic encephalopathy but will check ammonia
   - continue to trend LFTs
   - f/u ammonia level
   .
   # FEN: NPO with LR at 100cc/hr
   - replete electrolytes prn
   .
   # PPx: pneumoboots, famotidine IV
   .
   # Comm: With patient and Son [**Name (NI) 225**] at [**Telephone/Fax (1) 8018**]
   - needs ICU consent
   .
   # Access: right upper chest port and PIV,
   - will get 2^nd PIV
   .
   # Code: FULL CODE (confirmed with patient)
   .
   # Dispo: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Indwelling Port (PortaCath) - [**2180-6-15**] 06:16 PM
   20 Gauge - [**2180-6-16**] 06:41 AM x2
   Prophylaxis:
   DVT:
   Stress ulcer: famotidine
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU for methylene blue treatment<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 74-year-old woman with recurrent follicular cell lymphoma who presented for induction with protocol Ofatumumab/ICE and was transferred to the ICU for acute mental status changes and fever.

The patient's current condition is as follows:

* Vital signs: Temperature 101.8°F, Heart rate 105 bpm, Blood pressure 152/77 mmHg, Respiratory rate 19 breaths per minute, Oxygen saturation 97%
* Physical examination: The patient is oriented to person only, with dry skin on legs, and no rashes. She has cool extremities, 2+ radial and DP pulses, and no edema.
* Laboratory results: The patient's white blood cell count is 6.2 K/uL, hemoglobin is 8.1 g/dL, platelet count is 147 K/uL, and creatinine is 0.9 mg/dL. Her blood urea nitrogen is 24 mg/dL, and her lactate is 1.1 mmol/L. Her liver function tests are mildly elevated, with alanine aminotransferase (ALT) at 46 IU/L and aspartate aminotransferase (AST) at 38 IU/L.
* Imaging studies: The patient's computed tomography (CT) scan shows a possible right lower lobe (RLL) infiltrate, which was previously concerning for infection. The patient's magnetic resonance imaging (MRI) is pending.

The patient's diagnosis is altered mental status (not delirium) with nausea and vomiting. The etiology of the altered mental status is unclear, but it is likely related to Ofatumumab/ICE toxicity, infection, or a combination of both. The patient's fever, tachycardia, and tachypnea are also concerning for infection.

The patient's plan includes:

* Continuing methylene blue and thiamine for Ofatumumab/ICE toxicity
* Strict aspiration precautions
* Following up with neurology recommendations
* Continuing empiric vancomycin and piperacillin-tazobactam
* Following up with MRI and blood and urine cultures
* Following up with EEG

Potential medical complications that can arise include:

* Infection: The patient's fever, tachycardia, and tachypnea are concerning for infection. The patient's RLL infiltrate on CT scan may indicate pneumonia or other pulmonary infection.
* Neurotoxicity: The patient's altered mental status may be related to Ofatumumab/ICE toxicity, which can cause neurotoxicity.
* Hepatic encephalopathy: The patient's mildly elevated liver function tests may indicate liver dysfunction, which can lead to hepatic encephalopathy.
* Dehydration: The patient's fever and vomiting may lead to dehydration if not adequately managed.
* Respiratory failure: The patient's tachypnea and hypoxia may lead to respiratory failure if not adequately managed.
* Sepsis: The patient's infection and altered mental status may lead to sepsis if not adequately managed.

It is essential to closely monitor the patient's condition and adjust the plan accordingly to prevent these potential complications and ensure the patient's optimal care."
